Does TREMELIMUMAB Cause Neoplasm progression? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Neoplasm progression have been filed in association with TREMELIMUMAB (IMJUDO). This represents 0.8% of all adverse event reports for TREMELIMUMAB.
18
Reports of Neoplasm progression with TREMELIMUMAB
0.8%
of all TREMELIMUMAB reports
17
Deaths
12
Hospitalizations
How Dangerous Is Neoplasm progression From TREMELIMUMAB?
Of the 18 reports, 17 (94.4%) resulted in death, 12 (66.7%) required hospitalization.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREMELIMUMAB. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TREMELIMUMAB Cause?
Pyrexia (178)
Diarrhoea (136)
Death (116)
Colitis (115)
Pneumonitis (87)
Pneumonia (85)
Sepsis (82)
Vomiting (78)
Febrile neutropenia (72)
Malignant neoplasm progression (68)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TREMELIMUMAB Alternatives Have Lower Neoplasm progression Risk?
TREMELIMUMAB vs TREMELIMUMAB\TREMELIMUMAB-ACTL
TREMELIMUMAB vs TRENBOLONE
TREMELIMUMAB vs TREOSULFAN
TREMELIMUMAB vs TREPROSTINIL
TREMELIMUMAB vs TREPROSTINIL DIOLAMINE